Investment M&A is the only way for enterprises to grow and integrate and develop the industry. The injection and integration of the capital market has made the medical device industry a qualitative leap to a certain extent. According to the statistics of the Flint Creation Investment and Financing Platform, there were 24 investment M&A events in the global medical device industry in the first quarter of 2017, 6 in China and 18 in foreign countries, including 1 case of a newly established company. Among them, there were 7 cases of domestic and foreign mergers and acquisitions. Compared with the pharmaceutical industry, the number of companies in the medical device field, IPO, VC / PE is difficult to match. This phenomenon not only occurs in China, even in the United States. There are many reasons for each, there are reasons for policy approval, and there are also solid effects in the medical device industry. From the 25 M&A events of Q1, it is not difficult to find out the major characteristics of the current investment in the medical device industry: Mergers and acquisitions integrate and improve their product lines. Medical device giants frequently acquire small medical equipment companies and improve their product lines by integrating more resources. The medical device industry entered the peak of mergers and acquisitions and technology transfer. Investing in a large amount of M&A capital, which tends to be a product or market. The capital inflow of millions of billions of dollars reflects the considerable market potential of this industry, and of course it means huge market profits. Industry dispersion is high, there are many types of sub-categories, and investment opportunities are very large, but it is relatively difficult to master. From the dimension analysis of the amount of financing obtained by enterprises, there are 9 financings (in RMB) of more than 100 million yuan, accounting for 56.25% of all financing, and 5 investment of less than 100 million yuan and more than 10 million yuan, accounting for 31% of the total. 25%, the number of financing enterprises of one million yuan is only one, accounting for 6.25% of the total, and one company has not disclosed the specific financing amount of financing. This shows that the investment in the medical device industry is also quite high, although compared with the pharmaceutical industry, the demand for medical equipment is not so large, and the investment cycle is relatively short, but the risk is relatively low. Semi-Auto Chemistry Analyzer,Semi-Auto Biochemistry Analyzer,Biochemistry Analyzer,Semi-Automatic Clinical Chemistry Guangdong Widinlsa International Co.Ltd , https://www.widinlsa.com
